|
SHCBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.087400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.458970E-03 |
| Normal-vs-Stage2 |
7.529200E-01 |
| Normal-vs-Stage3 |
6.983600E-01 |
| Normal-vs-Stage4 |
1.737790E-02 |
| Stage1-vs-Stage2 |
2.440800E-01 |
| Stage1-vs-Stage3 |
5.118200E-02 |
| Stage1-vs-Stage4 |
4.767400E-04 |
| Stage2-vs-Stage3 |
6.426600E-01 |
| Stage2-vs-Stage4 |
1.912440E-01 |
| Stage3-vs-Stage4 |
1.238230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.924200E-01 |
| Normal-vs-AfricanAmerican |
4.122500E-03 |
| Normal-vs-Asian |
8.532600E-01 |
| Caucasian-vs-AfricanAmerican |
1.923930E-03 |
| Caucasian-vs-Asian |
8.715400E-01 |
| AfricanAmerican-vs-Asian |
3.518200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.537600E-01 |
| Normal-vs-Female |
4.879200E-01 |
| Male-vs-Female |
4.956400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.128800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.017600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.012800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.363000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.883600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.760600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.065800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.547200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.402600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.156100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.021860E-04 |
| Normal-vs-Grade 2 |
6.223500E-02 |
| Normal-vs-Grade 3 |
7.128200E-01 |
| Normal-vs-Grade 4 |
1.839600E-02 |
| Grade 1-vs-Grade 2 |
1.966340E-02 |
| Grade 1-vs-Grade 3 |
4.400900E-04 |
| Grade 1-vs-Grade 4 |
5.6093999999951E-05 |
| Grade 2-vs-Grade 3 |
1.499360E-01 |
| Grade 2-vs-Grade 4 |
1.697530E-03 |
| Grade 3-vs-Grade 4 |
1.222070E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.578600E-03 |
| Normal-vs-ccB subtype |
3.109000E-01 |
| ccA subtype-vs-ccB subtype |
1.161570E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.658800E-01 |
| Normal-vs-N1 |
9.182600E-03 |
| N0-vs-N1 |
2.179900E-04 |
|
|
